J. David Burkhardt, MD

Left Atrial Appendage Exclusion Using a LARIAT Device: A Case Study

08/27/2012

J. David Burkhardt , MD;

Andrea Natale , MD, FACC, FHRS, FESC;

Luigi Di Biase , MD, PhD, FHRS;

Rodney P. Horton , MD;

Pasquale Santangeli , MD;

IntroductionPatients with atrial fibrillation (AF) face an increased risk of systemic thromboembolism.1 The left atrial appendage (LAA), a remnant of the primordial left atrium, represents the major source of cardiac thrombus formation...

IntroductionPatients with atrial...

08/27/2012

EP Lab Digest

EP Year in Review: 2009

02/09/2010

Andrea Natale , MD, FACC, FHRS, FESC;

J. David Burkhardt , MD;

This month EP Lab Digest debuted online-only content on our website, including this feature article by J. David Burkhardt, MD, FACC and Andrea Natale, MD, FACC, FHRS. In the article, the authors discuss electrophysiology advancements from the...

This month EP Lab Digest debuted...

02/09/2010

EP Lab Digest

Review

Chronicling the Evolution of Catheter Ablation for Atrial Fibrillation and Ventricular Tachycardia

05/04/2009

Dimpi Patel , MD;

J. David Burkhardt , MD;

Javier E. Sanchez , MD;

Luigi Di Biase , MD, PhD, FHRS;

Rodney P. Horton , MD;

Andrea Natale , MD, FACC, FHRS, FESC;

Catheter Ablation for Atrial Fibrillation: An Attempt at Abating the Epidemic The evolution of catheter ablation for atrial fibrillation. Over the past decade, atrial fibrillation ablation (AF) has evolved from an investigational therapy to...

Catheter Ablation for Atrial...

05/04/2009

Journal of Invasive Cardiology

Review

Primary Ablation of Ventricular Tachycardia: In Search of a Better Strategy

09/26/2011

Pasquale Santangeli , MD;

J. David Burkhardt , MD;

Andrea Natale , MD, FACC, FHRS, FESC;

Dr. Santangeli et al summarize available evidence on primary ventricular tachycardia ablation, reviewing the techniques and results of this ablation strategy.

Dr. Santangeli et al summarize...

09/26/2011

EP Lab Digest